Sunmun Pharma was founded in the Republic of Belarus in March 2023. The company is based on the territory of the Great Stone industrial park. The main mission of the company is the transfer of modern pharmaceutical technologies and the organization of production and distribution of innovative medicines.
The company's portfolio includes drugs such as Rivaroxaban, Apixaban and Tikamun (Ticagrelor).
All of the company's drugs successfully undergo bioequivalence studies in various countries around the world, confirming that they are absolutely bioequivalent to the original drug and have comparable effectiveness, safety, and tolerability, while the price is more affordable.
Sanmun Pharma was founded in the Republic of Belarus in March 2023. The company is based in the Great Stone Industrial Park. Its main mission is the transfer of modern pharmaceutical technologies and the organization of production and distribution of innovative medicines.
The company's portfolio includes drugs such as "Rivaroxaban", "Apixaban", and "Tikamun" (Ticagrelor).
All of the company's drugs successfully undergo bioequivalence studies in various countries around the world, confirming that they are fully bioequivalent to the original drug and offer comparable efficacy, safety, and tolerability, while being more affordable.